Apheresis in Neurological Disorders

Apheresis refers to an extracorporeal therapy which aims at removing pathological constituents from the patients' blood. Due to the development of new techniques as well as the discovery of novel autoimmune antibodies, it is increasingly recognized as an important therapeutic option for a varie...

Description complète

Enregistré dans:
Détails bibliographiques
Autres auteurs: Dorst, Johannes (Éditeur intellectuel)
Format: Électronique Chapitre de livre
Langue:anglais
Publié: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Sujets:
Accès en ligne:DOAB: download the publication
DOAB: description of the publication
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:Apheresis refers to an extracorporeal therapy which aims at removing pathological constituents from the patients' blood. Due to the development of new techniques as well as the discovery of novel autoimmune antibodies, it is increasingly recognized as an important therapeutic option for a variety of autoimmune-mediated neurological disorders, including multiple sclerosis, myasthenia gravis, autoimmune encephalitis, Guillain-Barré syndrome, and many others. Therapeutic plasma exchange (TPE) constitutes the standard method of apheresis for most indications, while immunoadsorption (IA) offers a more specific, low-risk alternative. Both methods aim at removing auto-antibodies from the blood. Evidence for most neurological diseases is still low. Interestingly, more recent developments suggest that apheresis is not limited to the removal of autoantibodies but may also be useful in neurodegenerative and possibly even in acute vascular disorders.
Description matérielle:1 electronic resource (174 p.)
ISBN:books978-3-03943-586-9
9783039435852
9783039435869
Accès:Open Access